Australian Health Authority To Allow Psilocybin And MDMA-Assisted Therapy For Depression, PTSD
Beginning on July 1, 2023, medicines containing psilocybin and MDMA can be prescribed by specifically authorized psychiatrists to treat certain mental health conditions, such as post-traumatic stress disorder and psilocybin for treatment-resistant depression.
The decision acknowledges the current lack of options for patients with specific treatment-resistant mental illnesses. It means that psilocybin and MDMA can be used therapeutically in a controlled medical setting.
Continue reading HERE.
Section 56 (1) Exemption Takes Effect Today In British Columbia
Acting to curb an unprecedented and deadly overdose crisis in the province...
Login or create a forever free account to read this news
Sign up/Log in